The data about deoxyribonuclease activity in blood of healthy donors and patients with malignant and autoimmune diseases are described. Methodological aspects of the analysis of DNase activity and factors which interfere with DNase activity in blood are discussed.
No takes yet. Share an insight, caveat, or question.
Cherepanova et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: